5-Monobutyl methotrexate
5-Monobutyl methotrexate (NSC 305986; γ-MBMTX) is a dihydrofolate reductase (DHFR) inhibitor and esterase substrate. 5-Monobutyl methotrexate is hydrolyzed by esterases to produce methotrexate. In rhesus monkeys, 5-Monobutyl methotrexate clears more slowly from cerebrospinal fluid than from serum, and its serum protein binding rate exceeds 99%. At the same dose rate, 5-Monobutyl methotrexate achieves cerebrospinal fluid concentrations comparable to those of Methotrexate (HY-14519), and exhibits activity against Methotrexate-resistant cells (with transport defects) that is comparable to that against sensitive parental cells. 5-Monobutyl methotrexate can be used in studies related to Methotrexate-resistant tumors.
For research use only. We do not sell to patients.
- CAS No.: 66147-31-7
- Formula: C24H30N8O5
- Molecular Weight:510.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
The binding rate of 5-Monobutyl methotrexate (74-290 μM; MeOH extract) to rhesus monkey serum albumin exceeds 99% at total concentrations of 74, 130, and 290 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Macaca mulatta (adult, 10-15 kg, male and female)[1]
-
Dosage:27 mg (bolus); 10 g/m2 (1.25-hour infusion); 10 g/m2 (4-hour infusion)
-
Administration:i.v. (bolus over 1-2 minutes); i.v. (infusion over 1.25 hours); i.v. (infusion over 4 hours)
-
Result:Accounted for 67%-94% of total serum radioactivity for up to 60 min, with [3H]MTX comprising 4%-13% and only traces of other products after intravenous bolus.
Reached approximately equal proportions with MTX in serum at 2 h after intravenous bolus.
Was the major species in urine over 60 minutes and up to 4 hours, declining from 95% to 54% of total urinary radioactivity, while MTX increased to 31% and other products increased to 15% after intravenous bolus.
Reached free serum level of 1×10-4 M at end of 1.25-h infusion, declining to 7×10-6 M over 5 h.
Peaked at 1.5×10-5 M in CSF after 1.25-h infusion, with CSF/serum ratios increasing from 0.15 at 2 h post-infusion to 1.0 at 5 h post-infusion.
Showed free serum MTX ranging from 1×10-5 M to 4.8×10-6 M over 5 h, with CSF MTX ranging from 4.7×10-6 M to 7.5×10-6 M, and CSF/serum MTX ratios consistently above 0.5 after 1.25-hour infusion.
Remained detectable in serum at 24 hours, with MTX present in CSF at 24 hours (≈4×10-6 M) after 1.25-hour infusion.
Had free serum levels roughly 50% lower than after 1.25-hour infusion at corresponding time points after 4-hour infusion.
Showed CSF levels following a similar lower pattern to serum after 4-hour infusion, with CSF/serum ratios increasing from 0.18 at end of infusion to 1.2 at 3 hours post-infusion.
Was below 1×10-6 M in free serum at 24 hours, while remaining above 4×10-6 M in CSF after 4-hour infusion.
Showed free serum MTX peaking at 5.4×10-4 M at 2 hours post-infusion, with MTX undetectable in CSF (<1×10-6 M) at all time points after 4-hour infusion.
Chemical Information
-
CAS No. 66147-31-7
-
Molecular Weight 510.55
-
Formula C24H30N8O5
-
SMILES
NC1=NC(N)=NC(N=C2)=C1N=C2CN(C(C=C3)=CC=C3C(N[C@H](C(O)=O)CCC(OCCCC)=O)=O)C
-
Synonyms
NSC 305986; γ-MBMTX
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)